You are here

  • Home
  • Archive
  • Volume 24, Issue Suppl 1
  • CP-059 Efficacy and cost of direct acting antivirals for the treatment of hcv infection among HCV monoinfected and HIV/HCV coinfected patients in real life setting

Article Text

Article menu
Download PDFPDF
Clinical pharmacy
CP-059 Efficacy and cost of direct acting antivirals for the treatment of hcv infection among HCV monoinfected and HIV/HCV coinfected patients in real life setting
  1. G Corinaldesi1,
  2. R Sentinelli1,
  3. S Guglielmi1,
  4. V Barocci2,
  5. S Castelletti2,
  6. I Pierantonelli3,
  7. S Gemini4,
  8. A Riva5,
  9. M Martini6,
  10. A Costantini6
  1. 1AO Ospedali Riuniti Ancona, Pharmacy Unit, Ancona, Italy
  2. 2AO Ospedali Riuniti Ancona, Clinic of Infectious Diseases, Ancona, Italy
  3. 3AO Ospedali Riuniti Ancona, Clinical Gastroenterology Unit, Ancona, Italy
  4. 4AO Ospedali Riuniti Ancona, Gastroenterology Unit, Ancona, Italy
  5. 5AO Ospedali Riuniti Ancona, Infectious Diseases Unit, Ancona, Italy
  6. 6AO Ospedali Riuniti Ancona, Clinical Immunology, Ancona, Italy

Abstract

This abstract was published in error and withdrawn at the author’s request.

https://doi.org/10.1136/ejhpharm-2017-000640.58

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.